1. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
2. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN 517 Guidelines®) for Non Small Cell Lung Cancer V.1.2023. ©National Comprehensive Cancer Network, Inc. 2023. All rights reserved (accessed 15 June 2023). To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
3. N. Howlader, A.M. Noone, M. Krapcho, D. Miller, A. Brest, M. Yu, J. Ruhl, Z. Tatalovich, A. Mariotto, D.R. Lewis, H.S. Chen, E.J. Feuer, K.A. Cronin (eds), SEER Cancer Statistics Review, 1975-2018, based on November 2020 SEER data submission, posted to the SEER website, April 2021. Bethesda, MD: National Cancer Institute 2020. Available at: https://seer.cancer.gov/archive/csr/1975_2018/ (accessed 15 June 2023).
4. Genetic alterations defining NSCLC subtypes and their therapeutic implications;Pikor;Lung Cancer,2013
5. M.A. Bareschino, C. Schettino, A. Rossi, P. Maione, P.C. Sacco, R. Zeppa, C. Gridelli, Treatment of advanced non small cell lung cancer, J. Thorac. Dis. 3 (2011) 122–133.